Pharmacology
Latest articles
- Restricted accessTarget Doses of Heart Failure Medical Therapy and Blood PressureInsights From the CHAMP-HF RegistryPoghni A. Peri-Okonny, John A. Spertus, et al.
- Restricted accessSafety of Alpha-Adrenergic Receptor Antagonists in Heart FailureWen-Qin Guo, Xie-Hui Chen, et al.
- Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in WomenA Systematic Review of the LiteratureSophie H. Bots, Hester M. den Ruijter, et al.
- Restricted accessApplying Network Meta-Analysis to Cardiovascular Outcome Trials of Glucose-Lowering DrugsSean L. Zheng, Alistair J. Roddick, et al.
- Restricted accessReplyCatecholamine-Mediated Pathways in Takotsubo Syndrome: Does it Matter If it Is a Serotonin Norepinephrine Reuptake Inhibitor or a Selective Serotonin Reuptake Inhibitor?Daniel Woronow, Cindy Kortepeter, et al.
Review articles
- Restricted accessPatients Not Meeting PARADIGM-HF Enrollment Criteria Are Eligible for Sacubitril/Valsartan on the Basis of FDA ApprovalThe Need to Close the GapAntonio L. Perez, Randall C. Starling, et al.
- Restricted accessAntiplatelet and Anticoagulant Agents in Heart FailureCurrent Status and Future PerspectivesPaul A. Gurbel, Udaya S. Tantry, et al.
- Restricted accessDrug Therapy to Reduce Early Readmission Risk in Heart FailureReady for Prime Time?Muthiah Vaduganathan, Mihai Gheorghiade, et al.
- Restricted accessNitrate Therapy for Heart FailureBenefits and Strategies to Overcome ToleranceDivya Gupta, Javed Butler, et al.
Advertisement
Advertisement